Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Hepatitis and other GI infections

Danish patients with alcoholic cirrhosis have a low risk of hepatocellular carcinoma thus raising questions about the utility of screening
Jamile’ Wakim-Fleming, Rocio Lopez

BMJ Evidence-Based Medicine Aug 2013, 18 (4) 155-156; DOI: 10.1136/eb-2012-100959
Value and usability of unpublished data sources for systematic reviews and network meta-analyses
Nicholas James Anthony Halfpenny, Joan Mary Quigley, Juliette Catherine Thompson, David Alexander Scott

BMJ Evidence-Based Medicine Dec 2016, 21 (6) 208-213; DOI: 10.1136/ebmed-2016-110494
An interferon-free, all-oral regimen is effective in treatment of genotype 1 chronic HCV infection
Andrew W Tai

BMJ Evidence-Based Medicine Apr 2014, 19 (2) 67; DOI: 10.1136/eb-2013-101566
Telaprevir triple combination therapy, and dual peginterferon α-2a/ribavirin therapy for 24 weeks for those with rapid-early response is not inferior to 48 weeks of therapy for treatment-naïve patients with genotype 1 hepatitis C virus infection
Mark Danta

BMJ Evidence-Based Medicine Oct 2012, 17 (5) 143-144; DOI: 10.1136/ebmed-2011-100469
In patients with a first episode of severe alcoholic hepatitis non-responsive to medical therapy, early liver transplant increases 6-month survival
Michael R Lucey

BMJ Evidence-Based Medicine Feb 2013, 18 (1) 21-22; DOI: 10.1136/ebmed-2012-100541
Treatment of hepatitis C, then, now and tomorrow
Richard K Sterling, Narayan Dharel

BMJ Evidence-Based Medicine Feb 2015, 20 (1) 23; DOI: 10.1136/ebmed-2014-110103
ABT-450/r-ombitasvir and dasabuvir with ribavirin eliminates viraemia in most patients with HCV infection with cirrhosis
Valérie Martel-Laferrière

BMJ Evidence-Based Medicine Feb 2015, 20 (1) 6; DOI: 10.1136/ebmed-2014-110055
Sofosbuvir with ribavirin is safe and effective in hepatitis C genotype 1 with unfavourable pretreatment characteristics
McKenzie C Ferguson

BMJ Evidence-Based Medicine Jun 2014, 19 (3) 90; DOI: 10.1136/eb-2013-101592
Surveillance for hepatocellular carcinoma with ultrasound and AFP is associated with improvements in tumour detection, receipt of curative therapy and overall survival in patients with cirrhosis
Danielle A Bischof, Timothy M Pawlik

BMJ Evidence-Based Medicine Dec 2014, 19 (6) 225-226; DOI: 10.1136/ebmed-2014-110036
Malaria vaccine was safe for infants and did not interfere with the immunogenicity of coadministered antigens
BMJ Evidence-Based Medicine Jun 2009, 14 (3) 87; DOI: 10.1136/ebm.14.3.87

Pages